A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/44 (2006.01) A61K 31/4412 (2006.01) A61K 31/4985 (2006.01) A61K 31/5025 (2006.01) A61K 31/506 (2006.01) A61K 31/519 (2006.01) A61K 31/53 (2006.01) A61P 9/12 (2006.01)
Patent
CA 2604295
The invention relates to the use of Roflumilast, Roflumilast-N-Oxide or a pharmaceutically acceptable salt of either for the treatment of pulmonary hypertension. The invention additionally relates to the use of Roflumilast, Roflumilast-N-oxide or a pharmaceutically acceptable salt of either in combination with a PDE5 inhibitor or a pharmaceutically acceptable salt thereof for the treatment of pulmonary hypertension.
La présente invention se rapporte à l'utilisation de roflumilast, de roflumilast-n-oxyde ou d'un sel pharmaceutiquement acceptable d'un de ces derniers, pour traiter l'hypertension pulmonaire. L'invention a également trait à l'utilisation de roflumilast, de roflumilast-n-oxyde ou d'un sel pharmaceutiquement acceptable d'un de ces derniers en combinaison avec un inhibiteur PDE5 ou un sel pharmaceutiquement acceptable de ce dernier, pour traiter l'hypertension pulmonaire.
Adnot Serge
Beume Rolf
Eddahibi Saadia
Hatzelmann Armin
Marx Degenhard
Gowling Lafleur Henderson Llp
Nycomed Gmbh
LandOfFree
Roflumilast for the treatment of pulmonary hypertension does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Roflumilast for the treatment of pulmonary hypertension, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Roflumilast for the treatment of pulmonary hypertension will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1501386